Eli Lilly & Co. (LLY) Tops Q1 EPS by 2c
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,190.01 -0.79%
Revenue Growth %: +31.7%
Financial Fact:
Cost of sales: 1.4B
Today's EPS Names:
CRMT, FOMI, FLES, More
Revenue Growth %: +31.7%
Financial Fact:
Cost of sales: 1.4B
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $0.98, $0.02 better than the analyst estimate of $0.96. Revenue for the quarter came in at $5.23 billion versus the consensus estimate of $5.21 billion.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
- Sandoz submits generic obesity drug applications to FDA
- Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
